LTPA2021002I1 - Kvinolono junginių gamybos būdas - Google Patents
Kvinolono junginių gamybos būdasInfo
- Publication number
- LTPA2021002I1 LTPA2021002I1 LTPA2021002C LTPA2021002C LTPA2021002I1 LT PA2021002 I1 LTPA2021002 I1 LT PA2021002I1 LT PA2021002 C LTPA2021002 C LT PA2021002C LT PA2021002 C LTPA2021002 C LT PA2021002C LT PA2021002 I1 LTPA2021002 I1 LT PA2021002I1
- Authority
- LT
- Lithuania
- Prior art keywords
- production
- quinolone compounds
- quinolone
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19408308P | 2008-09-24 | 2008-09-24 | |
| PCT/US2009/005276 WO2010036329A2 (en) | 2008-09-24 | 2009-09-23 | Process for making quinolone compounds |
| EP09816565.7A EP2346855B1 (en) | 2008-09-24 | 2009-09-23 | Process for making quinolone compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LTPA2021002I1 true LTPA2021002I1 (lt) | 2021-03-10 |
| LTC3214083I2 LTC3214083I2 (lt) | 2022-06-27 |
Family
ID=42060333
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP20191961.0T LT3766876T (lt) | 2008-09-24 | 2009-09-23 | Farmacinė vaisto forma, turinti chinolono darinį |
| LTEP17163383.7T LT3214083T (lt) | 2008-09-24 | 2009-09-23 | Kvinolono junginių gamybos būdas |
| LTPA2021002C LTC3214083I2 (lt) | 2008-09-24 | 2021-02-17 | Kvinolono junginių gamybos būdas |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP20191961.0T LT3766876T (lt) | 2008-09-24 | 2009-09-23 | Farmacinė vaisto forma, turinti chinolono darinį |
| LTEP17163383.7T LT3214083T (lt) | 2008-09-24 | 2009-09-23 | Kvinolono junginių gamybos būdas |
Country Status (27)
| Country | Link |
|---|---|
| US (3) | USRE46617E1 (lt) |
| EP (3) | EP3766876B8 (lt) |
| JP (2) | JP6013734B2 (lt) |
| KR (3) | KR20110091504A (lt) |
| CN (2) | CN102164912B (lt) |
| AU (1) | AU2009297085B2 (lt) |
| BR (1) | BRPI0919241B8 (lt) |
| CA (1) | CA2738236C (lt) |
| CY (1) | CY1123658T1 (lt) |
| DK (2) | DK2346855T3 (lt) |
| ES (3) | ES2629466T3 (lt) |
| FI (1) | FI3766876T3 (lt) |
| HK (2) | HK1214243A1 (lt) |
| HR (1) | HRP20201879T1 (lt) |
| HU (2) | HUE052219T2 (lt) |
| IL (1) | IL211845A (lt) |
| LT (3) | LT3766876T (lt) |
| MX (2) | MX2011003122A (lt) |
| NL (1) | NL301091I2 (lt) |
| NO (1) | NO2021006I1 (lt) |
| PL (2) | PL3766876T3 (lt) |
| PT (1) | PT3214083T (lt) |
| RS (1) | RS61194B1 (lt) |
| RU (1) | RU2546667C2 (lt) |
| SG (1) | SG10201605492YA (lt) |
| SI (1) | SI3214083T1 (lt) |
| WO (1) | WO2010036329A2 (lt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7576216B2 (en) * | 2004-07-30 | 2009-08-18 | Abbott Laboratories | Preparation of pyridonecarboxylic acid antibacterials |
| KR20110091504A (ko) * | 2008-09-24 | 2011-08-11 | 립-엑스 파마슈티칼즈, 인크. | 퀴놀론 화합물의 제조 방법 |
| TW201444558A (zh) * | 2013-03-15 | 2014-12-01 | Melinta Therapeutics Inc | 使用喹諾酮類抗生素治療淋病感染的方法 |
| CN104098548B (zh) * | 2013-04-11 | 2017-07-18 | 上海医药工业研究院 | 一种Delafloxacin的精制方法 |
| CN103709100A (zh) * | 2013-12-31 | 2014-04-09 | 南京工业大学 | 一种8-氯代喹诺酮衍生物的制备方法 |
| TW201605447A (zh) * | 2014-06-20 | 2016-02-16 | 美林塔治療學有限公司 | 處理感染的方法 |
| CN106256824B (zh) * | 2015-06-18 | 2020-10-27 | 重庆医药工业研究院有限责任公司 | 一种高纯度德拉沙星葡甲胺盐的制备方法 |
| CN105017224A (zh) * | 2015-07-10 | 2015-11-04 | 扬子江药业集团有限公司 | 一种德拉沙星葡甲胺晶型的制备方法 |
| CN107778293B (zh) * | 2016-08-29 | 2023-06-16 | 鲁南制药集团股份有限公司 | 一种改进的德拉沙星的制备方法 |
| BR112019020401A2 (pt) | 2017-03-31 | 2020-04-22 | Fujifilm Corp | composto 4-piridona ou seu sal, e composição farmacêutica e formulação que inclui o mesmo |
| WO2022240897A1 (en) | 2021-05-10 | 2022-11-17 | Sepelo Therapeutics, Llc | Pharmaceutical composition comprising delafloxacin for administration into the lung |
| CN113527262B (zh) * | 2021-06-22 | 2022-07-15 | 安徽普利药业有限公司 | 一种德拉沙星及其葡甲胺盐的精制方法 |
| CN114031607B (zh) * | 2021-11-16 | 2023-01-10 | 海南普利制药股份有限公司 | 一种德拉沙星及其中间体的精制方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| JP3103380B2 (ja) | 1995-09-22 | 2000-10-30 | 湧永製薬株式会社 | 新規ピリドンカルボン酸誘導体又はその塩並びに該物質を有効成分とする抗菌剤 |
| PT1193266E (pt) * | 1999-07-01 | 2003-12-31 | Wakunaga Pharma Co Ltd | Derivado do acido quinolinacarboxilico e os sais dele derivados |
| JP2005097116A (ja) | 1999-11-11 | 2005-04-14 | Wakunaga Pharmaceut Co Ltd | キノリンカルボン酸誘導体アルカリ金属塩及びこれを用いたキノリンカルボン酸誘導体の精製法 |
| WO2006015194A2 (en) * | 2004-07-30 | 2006-02-09 | Abbott Laboratories | Preparation of pyridonecarboxylic acid antibacterials |
| DK3056492T3 (da) | 2004-10-08 | 2021-12-13 | Abbvie Inc | Megluminsalt og krystallinke former deraf af et lægemiddel (delafloxacin) |
| PL1868581T3 (pl) * | 2005-04-11 | 2012-08-31 | Abbvie Inc | Kompozycje farmaceutyczne słabo rozpuszczalnych leków o polepszonych profilach rozpuszczania |
| KR20110091504A (ko) | 2008-09-24 | 2011-08-11 | 립-엑스 파마슈티칼즈, 인크. | 퀴놀론 화합물의 제조 방법 |
-
2009
- 2009-09-23 KR KR1020117009326A patent/KR20110091504A/ko active Application Filing
- 2009-09-23 CA CA2738236A patent/CA2738236C/en active Active
- 2009-09-23 PL PL20191961.0T patent/PL3766876T3/pl unknown
- 2009-09-23 KR KR1020177008707A patent/KR20170039758A/ko not_active Application Discontinuation
- 2009-09-23 SG SG10201605492YA patent/SG10201605492YA/en unknown
- 2009-09-23 DK DK09816565.7T patent/DK2346855T3/en active
- 2009-09-23 BR BRPI0919241A patent/BRPI0919241B8/pt active IP Right Grant
- 2009-09-23 SI SI200932102T patent/SI3214083T1/sl unknown
- 2009-09-23 PL PL17163383T patent/PL3214083T3/pl unknown
- 2009-09-23 EP EP20191961.0A patent/EP3766876B8/en active Active
- 2009-09-23 LT LTEP20191961.0T patent/LT3766876T/lt unknown
- 2009-09-23 WO PCT/US2009/005276 patent/WO2010036329A2/en active Application Filing
- 2009-09-23 ES ES09816565.7T patent/ES2629466T3/es active Active
- 2009-09-23 US US14/743,365 patent/USRE46617E1/en active Active
- 2009-09-23 PT PT171633837T patent/PT3214083T/pt unknown
- 2009-09-23 FI FIEP20191961.0T patent/FI3766876T3/fi active
- 2009-09-23 JP JP2011529013A patent/JP6013734B2/ja active Active
- 2009-09-23 DK DK17163383.7T patent/DK3214083T3/da active
- 2009-09-23 KR KR1020167026280A patent/KR101775304B1/ko active IP Right Grant
- 2009-09-23 EP EP09816565.7A patent/EP2346855B1/en active Active
- 2009-09-23 US US13/120,278 patent/US8497378B2/en not_active Ceased
- 2009-09-23 CN CN200980138280.XA patent/CN102164912B/zh active Active
- 2009-09-23 ES ES20191961T patent/ES2966093T3/es active Active
- 2009-09-23 AU AU2009297085A patent/AU2009297085B2/en active Active
- 2009-09-23 ES ES17163383T patent/ES2826273T3/es active Active
- 2009-09-23 LT LTEP17163383.7T patent/LT3214083T/lt unknown
- 2009-09-23 EP EP17163383.7A patent/EP3214083B1/en active Active
- 2009-09-23 RU RU2011116052/04A patent/RU2546667C2/ru active
- 2009-09-23 MX MX2011003122A patent/MX2011003122A/es active IP Right Grant
- 2009-09-23 HU HUE17163383A patent/HUE052219T2/hu unknown
- 2009-09-23 CN CN201510401546.2A patent/CN105001207A/zh active Pending
- 2009-09-23 RS RS20201519A patent/RS61194B1/sr unknown
-
2011
- 2011-03-22 IL IL211845A patent/IL211845A/en active IP Right Grant
- 2011-03-23 MX MX2020009790A patent/MX2020009790A/es unknown
-
2013
- 2013-07-09 US US13/937,488 patent/US8871938B2/en active Active
-
2015
- 2015-05-19 JP JP2015101828A patent/JP2015178515A/ja active Pending
-
2016
- 2016-02-23 HK HK16101979.5A patent/HK1214243A1/zh unknown
-
2018
- 2018-03-05 HK HK18103144.9A patent/HK1244481A1/zh unknown
-
2020
- 2020-11-25 HR HRP20201879TT patent/HRP20201879T1/hr unknown
- 2020-12-09 CY CY20201101168T patent/CY1123658T1/el unknown
-
2021
- 2021-02-04 NL NL301091C patent/NL301091I2/nl unknown
- 2021-02-10 HU HUS2100004C patent/HUS2100004I1/hu unknown
- 2021-02-15 NO NO2021006C patent/NO2021006I1/no unknown
- 2021-02-17 LT LTPA2021002C patent/LTC3214083I2/lt unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTPA2021002I1 (lt) | Kvinolono junginių gamybos būdas | |
| BR112012004707A2 (pt) | método | |
| BR112012000624A2 (pt) | método | |
| FI20090389A0 (fi) | Menetelmä | |
| BRPI0919116A2 (pt) | método | |
| BRPI0920540A2 (pt) | método de produção de álcool | |
| BRPI1012526A2 (pt) | método | |
| DK2313489T3 (da) | Fremstillingsmetode | |
| BRPI1010705A2 (pt) | método | |
| BRPI0922490A2 (pt) | Método para produção de beta-santaleno | |
| BR112012014162A2 (pt) | método de fabricação de uma nanomanta | |
| BRPI1012532A2 (pt) | método | |
| BR112013016073A2 (pt) | método para produçao de compostos orgânicos | |
| BRPI0916597A2 (pt) | Método | |
| IS8917A (is) | Aðferð til að smíða skó | |
| BRPI1009350A2 (pt) | método | |
| DK2346661T3 (da) | Dannelsesfremgangsmåder | |
| BRPI0911286A2 (pt) | Método aperfeiçoado de produção de biodisel | |
| BRPI0913890A2 (pt) | Método para produção de ácido 3-metil-2tiofenocarboxílico | |
| BRPI0815419A2 (pt) | Método de produção | |
| DK2294043T3 (da) | Fremgangsmåde til fremstilling af glycerolalkyletere | |
| PL385356A1 (pl) | Sposób wytwarzania tadalafilu | |
| BRPI1011567A2 (pt) | método de tratar fragilidade | |
| BRPI1012010A2 (pt) | método de produção de ácido succínico | |
| TH123098B (th) | กระบวนการผลิตวัตถุที่ต้านอาวุธที่มีการปรับปรุงให้ดีขึ้น |